In recent years, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as effective therapeutic agents, as they stimulate insulin secretion and suppress glucagon release in a glucose-dependent manner, thereby improving glycemic control with a low risk of hypoglycemia [2]
Who should not take Qsymia
Lynn Grieger, RDN, CDCES Medical Reviewer Lynn Grieger is a registered dietitian-nutritionist, certified diabetes care and education specialist, certified personal trainer, and certified health and wellness coach
Insert the needle into the vial without pushing or pulling the plunger
Knapen LM, van Dalem J, Keulemans YC, van Erp NP, Bazelier MT, De Bruin ML,